Literature DB >> 21936121

Chronic cholestasis following prolonged tolbutamide administration.

D H Gregory, G F Zaki, G A Sarcosi, J B Carey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 21936121

Source DB:  PubMed          Journal:  Arch Pathol        ISSN： 0363-0153


× No keyword cloud information.
  6 in total

1.  Erythromycin-induced primary biliary cirrhosis.

Authors:  D A Lazarczyk; M C Duffy
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

Review 3.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

4.  Carbamazepine-induced acute cholangitis.

Authors:  D Larrey; A Hadengue; D Pessayre; L Choudat; C DeGott; J P Benhamou
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

5.  Favorable effects of glibenclamide in a patient exhibiting idiosyncratic hepatotoxic reactions to both chlorpropamide and tolbutamide.

Authors:  Z Rumboldt; B Bota
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

Review 6.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.